Malignant Hyperthermia in a Child with Duchenne Muscular Dystrophy
1 Departments of Pediatrics (Neurology) and Anesthesiology, Boston Floating Hospital, New England Medical Center, Boston
Patients with Duchenne muscular dystrophy (DMD) are susceptible to numerous adverse intraoperative and postoperative side effects of anesthetic agents. These include: hyperthermia and hyperkalemia,1,2 systemic acidosis,3 cardiac abnormalities (tachycardia, arrhythmia, arrest),2-5 rhabdomyolysis,2-6 as well as death.2,5 These clinical and laboratory findings are similar to those associated with malignant hyperthermia (MH).7,8 Until this time no one has confirmed the association of MH, as reflected by these clinical phenomena, in a patient with DMD. We present a patient who manifested many features of MH immediately following confirmatory muscle biopsy for DMD under general anesthesia. In vitro response to testing of a muscle biopsy specimen was consistent with a diagnosis of malignant hyperthermia.
This article has been cited by other articles:
![]() |
J. R. Mendell, C. H. Buzin, J. Feng, J. Yan, C. Serrano, D. S. Sangani, C. Wall, T. W. Prior, and S. S. Sommer Diagnosis of Duchenne dystrophy by enhanced detection of small mutations Neurology, August 28, 2001; 57(4): 645 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.E. McLeod and R.E. Creighton Review Article: Anesthesia for Pediatric Neurological and Neuromuscular Diseases J Child Neurol, July 1, 1986; 1(3): 189 - 197. [Abstract] [PDF] |
||||






